CVR: 34090106
TRACER PHARMA ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2011 and dissolved in 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 5 employees. In 2025, the company reported a gross profit of DKK 5,203,816 and a net result of DKK 687,871 compared with DKK 1,705,344 the year before. Equity amounted to DKK 867,174.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 5.2 mio. | 688 t. | 2.3 mio. | 867 t. | 3 | |
| 2024 | 5.4 mio. | 1.7 mio. | 4.7 mio. | 2.1 mio. | 3 | |
| 2023 | 4.1 mio. | 97 t. | 3 mio. | 1.4 mio. | 5 | |
| 2022 | 3.9 mio. | 145 t. | 3.4 mio. | 1.6 mio. | 5 | |
| 2021 | 4 mio. | 832 t. | 3.2 mio. | 1.5 mio. | 5 | |
| 2020 | 4.4 mio. | 455 t. | 2.5 mio. | 650 t. | 5 | |
| 2019 | 3 mio. | -330 t. | 2.9 mio. | 194 t. | - | |
| 2018 | 3.3 mio. | 417 t. | 3 mio. | 525 t. | 4 | |
| 2017 | 2.5 mio. | 20 t. | 3.5 mio. | 227 t. | 4 | |
| 2016 | 3.1 mio. | 123 t. | 3.4 mio. | 207 t. | - | |
| 2015 | 2.2 mio. | 30 t. | 4.9 mio. | 114 t. | - | |
| 2014 | 2 mio. | 123 t. | 1.6 mio. | 204 t. | - |
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreCompared to 1.054 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
As of November 28, 2025, Enver Edwin Medjedovic Hansen has stepped down as liquidator of TRACER PHARMA ApS.
On November 28, 2025, TRACER PHARMA ApS exited liquidation.
TRACER PHARMA ApS was dissolved on November 28, 2025.
TRACER PHARMA ApS has published its annual report for 2025. Gross profit came to DKK 5,203,816, and the net result was DKK 687,871.
As of April 1, 2025, Enver Edwin Medjedovic Hansen is registered as liquidator of TRACER PHARMA ApS.
As of April 1, 2025, Morten Hagelsten Jacobsen has stepped down as adm. dir. of TRACER PHARMA ApS.
On April 1, 2025, TRACER PHARMA ApS entered liquidation.
TRACER PHARMA ApS has published its annual report for 2024. Gross profit came to DKK 5,412,899, and the net result was DKK 1,705,344.
TRACER PHARMA ApS has published its annual report for 2023. Gross profit came to DKK 4,076,390, and the net result was DKK 96,954.
TRACER PHARMA ApS has published its annual report for 2022. Gross profit came to DKK 3,883,373, and the net result was DKK 145,040.
TRACER PHARMA ApS has published its annual report for 2021. Gross profit came to DKK 3,967,674, and the net result was DKK 832,254.
TRACER PHARMA ApS has published its annual report for 2020. Gross profit came to DKK 4,367,226, and the net result was DKK 455,381.
TRACER PHARMA ApS has published its annual report for 2019. Gross profit came to DKK 3,026,965, and the net result was DKK -330,498.
TRACER PHARMA ApS has published its annual report for 2018. Gross profit came to DKK 3,300,692, and the net result was DKK 417,388.
As of January 21, 2019, Morten Hagelsten Jacobsen is registered as adm. dir. of TRACER PHARMA ApS.
As of January 21, 2019, Jette Bjerrum has stepped down as adm. dir. of TRACER PHARMA ApS.
TRACER PHARMA ApS has published its annual report for 2017. Gross profit came to DKK 2,509,298, and the net result was DKK 20,350.
TRACER PHARMA ApS has published its annual report for 2016. Gross profit came to DKK 3,105,057, and the net result was DKK 123,002.
TRACER PHARMA ApS has published its annual report for 2015. Gross profit came to DKK 2,168,728, and the net result was DKK 30,108.
TRACER PHARMA ApS has published its annual report for 2014. Gross profit came to DKK 2,016,489, and the net result was DKK 123,200.
TRACER PHARMA ApS has published its interim report for the period December 20, 2011 – April 30, 2013.
As of September 26, 2013, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of TRACER PHARMA ApS.
As of April 25, 2013, Jette Bjerrum is registered as adm. dir. of TRACER PHARMA ApS.
As of April 25, 2013, John Bo Jacobsen has stepped down as adm. dir. of TRACER PHARMA ApS.
As of December 20, 2011, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of TRACER PHARMA ApS.
As of December 20, 2011, John Bo Jacobsen is registered as adm. dir. of TRACER PHARMA ApS.
TRACER PHARMA ApS was founded on December 20, 2011.
Companies in the same industry and area
CVR 31591414
CVR 29312206
CVR 29829586
CVR 32551475
CVR 38892304
companydata.dk